Motilis Medica wins W.A. de Vigier Foundation Prize

The oldest and most generous prize for young Swiss entrepreneurs was awarded June 18 in Soloturn: the W.A. De Vigier Foundation recognized five young entrepreneurs for their forward-looking projects. They each received starting capital of 100,000 CHF. One of these prizes was won by the Lausanne Company Motilis Medica SA, whose CEO and co-founder, Vincent Schlageter, is a member of EPFL's Signal Processing Laboratory. His innovation: a pill which transforms itself into a "special agent" in the digestive system to pinpoint GI tract problems. Read the Press release (French).